Dipna Pharmachem Ltd Financials
Company Logo

Dipna Pharmachem Ltd Financial Statement

Dipna Pharmachem Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Dipna Pharmachem Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual164.34
Operating Expenses Annual160.91
Operating Profit Annual3.43
Interest Annual2.00
Depreciation0.02
Net Profit Annual1.09
Tax Annual0.33

Dipna Pharmachem Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning5.69
Cash Flow from Operations-5.42
Cash Flow from Investing-0.01
Cash Flow from Financing13.62
Cash Flow at the End13.88

Dipna Pharmachem Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)2.10
PBIT Margin (%)2.09
PBT Margin (%)1.05
Net PROFIT Margin (%)0.66
Return On Networth / Equity (%)3.52
Return On Networth /Employed (%)7.05
Return On Assets (%)2.24
Total Debt / Equity (X)0.57
Asset Turnover Ratio (%)3.38

Dipna Pharmachem Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual0.04
Total Current Assets Annual132.87
Non Current Assets Annual0.04
Total Shareholders Funds Annual37.52
Total Assets Annual132.91

Dipna Pharmachem Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 5, 2024, Dipna Pharmachem Ltd has a market capitalization of 22.65 Cr. Value Research classifies it as a Micro-Cap company.
No, Dipna Pharmachem Ltd is not debt-free with a debt-to-equity ratio of 0.52.
In FY 2023 , Dipna Pharmachem Ltd recorded a total revenue of approximately 164.34 Cr marking a significant milestone in the company's financial performance.
Dipna Pharmachem Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and 0.4% annually, respectively..
Dipna Pharmachem Ltd's current PE ratio is 20.78.
Dipna Pharmachem Ltd's ROCE averaged 10.1% from the FY ending March 2022 to 2024, with a median of 6.0%. It peaked at 18.5% in March 2022, reflecting strong capital efficiency over the period..
Dipna Pharmachem Ltd's latest EBIT is Rs. 3.42 Cr, surpassing the average EBIT of Rs. 2.65 Cr over the 5 years..